Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Vyvanse retail price?

See the DrugPatentWatch profile for Vyvanse

What is the current Vyvanse retail price?

Retail price for Vyvanse depends on the strength (for example, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg), whether you’re buying capsules or chewable tablets, and the pharmacy (or mail-order) you use. With only the prompt provided, there isn’t enough information to state a single “retail price” figure.

How much do pharmacies typically charge without insurance?

Uninsured “cash” pricing can vary widely by pharmacy and ZIP code, and it can also differ between brand Vyvanse and generic lisdexamfetamine (if available in your area). To get the most accurate retail number, you typically need:
- the exact Vyvanse formulation and dose, and
- your pharmacy (or ZIP code).

What price should you expect with common insurance plans?

With insurance, your out-of-pocket cost is usually a copay (or coinsurance) rather than the full cash retail price. The actual amount depends on:
- your plan’s formulary (tier placement),
- whether prior authorization or step therapy is required,
- and whether you’re using a pharmacy network.

Can I lower the cost with coupons or manufacturer savings?

Often, manufacturer savings programs or pharmacy discount cards can reduce the out-of-pocket cost, but eligibility rules vary (for example, commercial insurance vs. government plans, and whether you’re paying cash). The exact savings amount depends on your dose and where you purchase.

How can you get the exact Vyvanse retail price quickly?

If you tell me:
1) the Vyvanse strength (mg),
2) the form (capsules or chewables), and
3) your ZIP code (or pharmacy name),
I can help you narrow down the likely retail/cash price you’ll see locally and what to ask the pharmacist to confirm.

What I need from you to answer precisely

Reply with:
- Dose (e.g., 30 mg)
- Form (capsules or chewable)
- ZIP code or pharmacy name (optional but best)

Sources: none provided in the question.



Other Questions About Vyvanse :

why is generic vyvanse so expensive Is vyvanse a generic drug? Vyvanse cost per pill? Vyvanse price? Vyvanse generic? What is vyvanse generic name? Vyvanse other name?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The response appropriately concludes the claim “WARNING: ABUSE, MISUSE, AND ADDICTION” is supported and consistently aligns with the provided label excerpts describing the boxed warning, abuse/misuse/addiction risk, and related patient counseling and monitoring instructions.


Category Scores

Indication
100
Excellent
Indication
100
Excellent

Accurate Statements

The claim "WARNING: ABUSE, MISUSE, AND ADDICTION" is determined to be supported.
Supported by the provided BOXED WARNING text and related sections (5.1 Abuse, Misuse, and Addiction; 9.2 Abuse; 17 Patient Counseling Information).
The label includes a boxed warning and detailed sections stating VYVANSE has a high potential for abuse and misuse leading to substance use disorder/addiction, with risk of overdose and death, increased with higher doses or unapproved methods such as snorting or injection.
Matches the provided boxed warning and Section 5.1/9.2 text.
The label instructs clinicians to assess abuse risk before prescribing and to monitor during treatment, and instructs patient education/counseling on proper storage and disposal.
Matches provided boxed warning/Section 5.1 and Section 17 text.
VYVANSE is described as a Schedule II controlled substance containing lisdexamfetamine (a prodrug of amphetamine).
Supported by provided Section 9.1 Controlled Substance.

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The response evaluates only the presence and support for the boxed warning topic and does not add dosing, contraindications, or other treatment instructions beyond what is present in the provided label excerpts.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue

Suggested Improvement